The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes
    • eBooks

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2026 / November / ASCP 2026: Biomarker Testing in Gynecologic Oncology
Oncology Guidelines and Recommendations Molecular Pathology Professional Development Voices in the Community Profession

ASCP 2026: Biomarker Testing in Gynecologic Oncology

Brush up on clinical indications, testing methodologies, interpretation criteria, and common pitfalls

11/14/2026 Video 1 min read

Share

With so many biomarkers now guiding gynecologic cancer care, the testing landscape can be difficult to navigate. At the ASCP 2026 Annual Meeting, Gulisa Turashvili will guide learners through the key considerations, towards a  more confident approach to biomarker testing and reporting. Here, she previews the learning objectives.

The following transcript has been edited for clarity.

I'm Gulisa Turashvili and I'm an Associate Professor of Pathology at Harvard Medical School and gynecologic and breast pathologist at Mass General Brigham in Boston, Massachusetts, where I also serve as the Subspecialty Director of gynecologic pathology. 

Biomarker testing has become central to how we diagnose and manage gynecology cancers. However, in daily practice, choosing the right assay, interpreting the results correctly, and connecting it back to morphology remains a challenge for many pathologists.

This 60-minute session – navigating biomarker testing in gynecologic neoplasms: what, when, and why – takes a practical case-based approach to closing these gaps. The session will examine the key biomarkers relevant to gynecologic pathology including P16 immunohistochemistry and high-risk HPV testing as well as immunohistochemistry for DNA mismatch repair proteins, P-53, hormone receptors, HER2, PDL1, and folate receptor 1. Particular attention will be given to appropriate clinical indications, testing methodologies, interpretation criteria, and recognized pitfalls, as well as current guideline recommendations.

Digital whole slide images from representative cases will be presented throughout the session, paired with polling questions to reinforce key concepts and facilitate engagement of the audience.

By the end of the session, you will be able to list the key prognostic and predictive biomarkers in gynecologic neoplasms, describe the appropriate indication, testing methods, and interpretation categories for each of these biomarkers, discuss the clinical implications of biomarker testing in guiding diagnosis, prognosis, and clinical decision making for patients with gynecologic neoplasms. 

So if you work with gynecologic specimens and would like to improve your proficiency with a clearer, more confident approach to biomarker testing and reporting, this session is for you.

Thank you for your attention and hope to see you all in Montréal.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.